Ointment based on 100% dye of Aster gymnoscephalus (purple arnica), powder of Lycopodium clavatum (lycopodium) resulting from spores and sulfathiazole powder mixed in solid Vaseline for healing wounds with full and partial skin loss. The present invention refers to a pharmaceutical composition for healing wounds with total or partial skin loss, mainly referring to an ointment based on a dye of 100% Aster gymnoscephalus (purple arnica) (40 g), powder of Lycopodium clavatum (lycopodium) resulting from spores (5 g) and sulfathiazole powder (5g) mixed in 100 g of solid Vaseline, where the powder of Lycopodium and sulfathiazole are dissolved in the arnica dye for being subsequently mixed in the solid Vaseline obtaining as a result an analgesic, anti-inflammatory, healing and antibacterial ointment the purpose of the present invention refers to an ointment with analgesic, anti-inflammatory, healing and antibacterial ointment, thus the purpose of the invention is to provide an ointment for healing ulcers caused by pressure, which may be applied to all types of skin, except those of people with hypersensitivity to any of the components, which is applied topically every 8 hours, the absorption thereof is not systemic.La presente invención se refiere a ungüento a base de tintura 100% de Aster gymnoscephalus (árnica morada), polvo de Lycopodium clavatum (licopodio) derivado de esporas y sulfatiazol en polvo mezclados en vaselina sólida para cicatrizar lesiones con pérdida parcial y total de la piel. La presente invención se refiere a una composición farmacéutica para cicatrizar lesiones con pérdida parcial y total de la piel, particularmente se refiere a un ungüento que comprende tintura 100% de Aster gymnoscephalus (árnica morada) (40g), polvo de Lycopodium clavatum (licopodio) derivado de esporas (5g) y sulfatiazol en polvo (5g) mezclados en 100 g de vaselina sólida, en donde el polvo de licopodio y sulfatiazol son disueltos en la tintura de árnica para después ser mezclados
